Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study
Publication
, Conference
Aymong, E; Fahy, M; Lansky, A; Mehran, R; Grines, CL; Cox, DA; Garcia, CE; Tcheng, JE; Griffin, JJ; Guagliumi, G; Stuckey, T; Turco, M; Stone, GW
Published in: AMERICAN JOURNAL OF CARDIOLOGY
September 15, 2003
Duke Scholars
Published In
AMERICAN JOURNAL OF CARDIOLOGY
ISSN
0002-9149
Publication Date
September 15, 2003
Volume
92
Issue
6A
Start / End Page
142L / 143L
Location
WASHINGTON, D.C.
Publisher
EXCERPTA MEDICA INC
Conference Name
15th Annual Transcatheter Cardiovascular Therapeutics Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Aymong, E., Fahy, M., Lansky, A., Mehran, R., Grines, C. L., Cox, D. A., … Stone, G. W. (2003). Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study. In AMERICAN JOURNAL OF CARDIOLOGY (Vol. 92, pp. 142L-143L). WASHINGTON, D.C.: EXCERPTA MEDICA INC.
Aymong, E., M. Fahy, A. Lansky, R. Mehran, C. L. Grines, D. A. Cox, C. E. Garcia, et al. “Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study.” In AMERICAN JOURNAL OF CARDIOLOGY, 92:142L-143L. EXCERPTA MEDICA INC, 2003.
Aymong E, Fahy M, Lansky A, Mehran R, Grines CL, Cox DA, et al. Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study. In: AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 142L-143L.
Aymong, E., et al. “Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study.” AMERICAN JOURNAL OF CARDIOLOGY, vol. 92, no. 6A, EXCERPTA MEDICA INC, 2003, pp. 142L-143L.
Aymong E, Fahy M, Lansky A, Mehran R, Grines CL, Cox DA, Garcia CE, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Stone GW. Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study. AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 142L-143L.
Published In
AMERICAN JOURNAL OF CARDIOLOGY
ISSN
0002-9149
Publication Date
September 15, 2003
Volume
92
Issue
6A
Start / End Page
142L / 143L
Location
WASHINGTON, D.C.
Publisher
EXCERPTA MEDICA INC
Conference Name
15th Annual Transcatheter Cardiovascular Therapeutics Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology